Clinicopathological characteristics, prognostic factors, and outcomes of elderly patients with lymphoma‐associated hemophagocytic lymphohistiocytosis: A multicenter analysis
Cancer Medicine · 2024
DOI: 10.1002/cam4.70178 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Yi Miao und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Capability Improvement Project through Science, Technology and Education, Postgraduate Research & Practice Innovation Program of Jiangsu Province, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Background
Lymphoma is the most common secondary cause of hemophagocytic lymphohistiocytosis (HLH) in adults. Lymphoma‐associated HLH (LA‐HLH) in the elderly population is not rare, however, little has been reported regarding clinicopathological characteristics, prognostic factors, and outcomes of LA‐HLH in the elderly population.
Methods
We retrospectively analyzed a multicenter cohort of elderly patients with LA‐HLH. Clinicopathological features and treatment information were collected. The impacts of baseline characteristics and treatments on survival outcomes were analyzed.
Results
A total of 173 elderly patients with LA‐HLH were included. Compared with young patients, elderly patients showed different clinical and laboratory features. Regarding lymphoma subtypes, B‐cell lymphoma was more common in elderly patients (elderly 61.3% vs. young 32.3%, p < 0.001) while T/NK‐cell lymphoma was more common in young patients (65.3% vs. 35.3%, p < 0.001). The median survival of elderly patients with LA‐HLH was only 92 days. The prior use of HLH therapy or etoposide‐containing HLH therapy was not associated with improved overall survival. T/NK‐cell subtype, a lower platelet count (≤53 × 10 9 /L), a lower albumin level (≤32.1 g/L), a higher LDH level (>1407 U/L), and a higher creatinine level (>96.8 μmol/L) were independent predictors of decreased overall survival and 60‐day survival. A prognostic index was established and demonstrated to be robust in predicting the overall survival and 60‐day survival of elderly patients with LA‐HLH.
Conclusions
LA‐HLH in elderly patients displayed heterogeneous clinicopathological features and survival outcomes. Treatments need to be optimized to improve the outcomes of elderly patients with LA‐HLH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group, Nanjing, China.
- Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, China.
- Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
- Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Hematology, The First People's Hospital of Huai'an, Huai'an, China.
ORCID-Profile: Yi Miao, Bingzong Li, Jingyan Xu, Jun Qian, Jianyong Li, Wenyu Shi
Förderung
- Jiangsu Province Capability Improvement Project through Science, Technology and Education
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- the Social Development Project of Jiangsu Province Science and Technology Plan
Zitieren
APA
Miao, Y., Zhang, J., Lu, X., Wu, M., Li, B., Yu, L., Sun, M., Zhuang, Y., Miao, Y., Ni, H., Xie, X., Xu, J., Zhang, Y., Zhao, M., Xu, M., Zhuang, W., Gu, W., Lin, G., Hua, H., …, & Shi, W. (2024). Clinicopathological characteristics, prognostic factors, and outcomes of elderly patients with lymphoma‐associated hemophagocytic lymphohistiocytosis: A multicenter analysis. Cancer Medicine. https://doi.org/10.1002/cam4.70178
Vancouver
Miao Y, Zhang J, Lu X, Wu M, Li B, Yu L, et al. Clinicopathological characteristics, prognostic factors, and outcomes of elderly patients with lymphoma‐associated hemophagocytic lymphohistiocytosis: A multicenter analysis. Cancer Medicine. 2024. doi:10.1002/cam4.70178
BibTeX
@article{Miao2024,
author = {Miao, Yi and Zhang, Jing and Lu, Xuzhang and Wu, Meng and Li, Bingzong and Yu, Liang and Sun, Miao and Zhuang, Yun and Miao, Yuqing and Ni, Haiwen and Xie, Xiaoyan and Xu, Jingyan and Zhang, Yunping and Zhao, Min and Xu, Min and Zhuang, Wanchuan and Gu, Weiying and Lin, Guoqiang and Hua, Haiying and Zhu, Jianfeng and Xu, Maozhong and Jia, Tao and Liu, Ping and Zhai, Lijia and Zhang, Tongtong and Shan, Qiurong and Shen, Qiudan and Qian, Jun and Wang, Chunling and Li, Jianyong and Shi, Wenyu},
title = {Clinicopathological characteristics, prognostic factors, and outcomes of elderly patients with lymphoma‐associated hemophagocytic lymphohistiocytosis: A multicenter analysis},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70178}
}
EUVIMED